Home / Share Price Target / Sanduphq
Sandu Pharmaceuticals Share Price Target 2024, 2025, 2026 to 2039 With Charts
Sandu Pharmaceuticals Limited | |||
 | Symbol: SANDUPHQ | ||
| Price: ₹56.79 | |||
| Exchange: BSE | |||
| -> | |||
Show Table of Contents
Table of Contents
- 0.1: Sandu Pharmaceuticals Financial Performance
- 0.1.1: Is Sandu Pharmaceuticals A Good Buy For Long Term?
- 1: Approach 1: Technical Analysis Paired With Price Action
- 1.1: Sandu Pharmaceuticals Share Price Target For 2024
- 1.1.1: Sandu Pharmaceuticals Share Price Target Table For 2024
- 1.1.2: Summary: Sandu Pharmaceuticals Share Price Prediction For 2024
- 1.2: Sandu Pharmaceuticals Share Price Target For 2025
- 1.2.1: Sandu Pharmaceuticals Share Price Target Table For 2025
- 1.2.2: Summary: Sandu Pharmaceuticals Share Price Prediction For 2025
- 2: Approach 2: Machine Learning By Studying Historical Prices
- 2.1: Sandu Pharmaceuticals Long Term Share Price Prediction Chart From 2024, 2025, 2026 to 2039
- 2.2: Sandu Pharmaceuticals Share Price Target Table From 2024, 2025, 2026 to 2039
- 3: Sandu Pharmaceuticals Past Performance
Sandu Pharmaceuticals Financial Performance
| Metric | Value | Description |
|---|---|---|
| Market Capital | 44.25 Crore | Market valuation of Sandu Pharmaceuticals's shares. |
| Revenue (TTM) | 65.34 Crore | Total revenue generated by Sandu Pharmaceuticals over the past twelve months. |
| Net Income (TTM) | +1.52 Crore | Net Profit or Loss after all the expenses over the past twelve months. |
| Operating Margin | 3.5% | Income from operations as a percentage of revenue, before taxes and interest. |
| Profit Margin | 50.63% | Net income as a percentage of revenue, after all expenses. |
| Revenue Growth (Quarterly) | +4.94% | Change in revenue compared to the previous quarter. |
Is Sandu Pharmaceuticals A Good Buy For Long Term?
Sandu Pharmaceuticals, a smallcap stock with 42.48 Crore market capitalization, exhibits a strong 50.63% profit margin and consistent growth, with a 4.94% revenue increase in the last quarter. While it has faced recent short-term setbacks, its long-term performance remains impressive, with substantial returns over 3, 5, and 12 months. Based on this data, Sandu Pharmaceuticals presents a compelling opportunity for long-term investors seeking stable growth and potential returns.
To predict the Sandu Pharmaceuticals's future market prices, we harnessed 2 dynamic approaches:
Approach 1: Technical Analysis Paired With Price Action
Approach 2: Machine Learning By Studying Historical Prices
Approach 1: Technical Analysis Paired With Price Action
Sandu Pharmaceuticals Share Price Target For 2024
The line chart displays the monthly closing prices of Sandu Pharmaceuticals with a black line. The green line shows three potential target prices for 2024, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Sandu Pharmaceuticals shares in 2024, see the table below.
Sandu Pharmaceuticals Share Price Target Table For 2024
| Sandu Pharmaceuticals's Levels | Value | Reason/Importance |
|---|---|---|
| 2024 Target 3 | 58.43 (+2.88%) | Price Action: 21 Oct 2024 High |
| 2024 Target 2 | 57.77 (+1.72%) | Price Action: 23 Oct 2024 High |
| 2024 Target 1 | 57.11 (+0.56%) | Price Action: 06 Nov 2024 Low |
| Current Price | 56.79 | Sandu Pharmaceuticals's 1 share price as of Fri 22 Nov 2024 |
| Stop Loss 1 | 56.63 (-0.29%) | Price Action: 21 Nov 2024 Low |
| Stop Loss 2 | 56.02 (-1.36%) | Fibonacci Retracement Level 98.6% |
| Stop Loss 3 | 55.34 (-2.56%) | Fibonacci Retracement Extended 40% |
Summary: Sandu Pharmaceuticals Share Price Prediction For 2024
In summary, Sandu Pharmaceuticals has declined by ₹-11.31, recording a notable -16.61% decrease from 1st January 2024 to 22 Nov 2024. Despite the setback, our analysis of Sandu Pharmaceuticals for 2024 predicts an additional rise of 0.56% to 2.88% by the end of 2024 with three potential targets T1: 57.11, T2: 57.77, T3: 58.43. Stop Loss at SL1: 56.63, SL2: 56.02, SL3: 55.34.
Sandu Pharmaceuticals has a 52-week high of ₹85.00, acting as a crucial resistance level - a ceiling that could challenge further price increase. Conversely, it has a 52-week low of ₹54.00, a critical support level - think of this as a safety net where the price might stop falling.
After looking at 2024's share price prediction, let's now check what 2025 might hold for Sandu Pharmaceuticals.
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Sandu Pharmaceuticals Share Price Target For 2025
The line chart displays the monthly closing prices of Sandu Pharmaceuticals with a black line. The green line shows three potential target prices for 2025, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Sandu Pharmaceuticals shares in 2025, see the table below.
Sandu Pharmaceuticals Share Price Target Table For 2025
| Sandu Pharmaceuticals's Levels | Value | Reason/Importance |
|---|---|---|
| 2025 Target 3 | 78.38 (+38.01%) | Price Action: Chart |
| 2025 Target 2 | 76.92 (+35.44%) | Price Action: Chart |
| 2025 Target 1 | 76.16 (+34.1%) | Custom Fibonacci Extension Lvl 64.9% |
| Current Price | 56.79 | Sandu Pharmaceuticals's 1 share price as of Fri 22 Nov 2024 |
| Stop Loss 1 | 52.10 (-8.26%) | Price Action: Apr 2023 Low |
| Stop Loss 2 | 51.58 (-9.18%) | Price Action: Chart |
| Stop Loss 3 | 50.25 (-11.52%) | Price Action: Mar 2023 Low |
Summary: Sandu Pharmaceuticals Share Price Prediction For 2025
In summary, Sandu Pharmaceuticals has declined by ₹-11.31, recording a notable -16.61% decrease from 1st January 2024 to 22 Nov 2024. Despite the setback, our analysis of Sandu Pharmaceuticals for 2025 predicts an additional rise of 34.1% to 38.01% by the end of 2025 with three potential targets T1: 76.16, T2: 76.92, T3: 78.38. Stop Loss at SL1: 52.10, SL2: 51.58, SL3: 50.25.
Sandu Pharmaceuticals has a All-Time high of ₹86.00, acting as a crucial resistance level - a ceiling that could challenge further price increase. Conversely, it has a 52-week low of ₹54.00, a critical support level - think of this as a safety net where the price might stop falling.
After looking at 2024's and 2025's share price prediction, you might wonder what are short term targets for Sandu Pharmaceuticals, we have created a specific page for that check here: Sandu Pharmaceuticals Share Price Target For Tomorrow & Next Week
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Approach 2: Machine Learning By Studying Historical Prices
Sandu Pharmaceuticals Long Term Share Price Prediction Chart From 2024, 2025, 2026 to 2039
This chart presents a detailed projection of Sandu Pharmaceuticals share price predictions from 2024, 2025, 2026 to 2039. This share price Prediction represents a CAGR of 5.64% over the next 15 years.
For complete year by year Sandu Pharmaceuticals long term share price target from 2024, 2025 to 2039 check the below table.
Sandu Pharmaceuticals Share Price Target Table From 2024, 2025, 2026 to 2039
| Year | Sandu Pharmaceuticals Target | YoY Change % |
|---|---|---|
| 2024 | ₹56.79 | [Current Price] |
| 2024 | ₹57.74 | 1.67% |
| 2025 | ₹51.93 | -10.07% |
| 2026 | ₹50.07 | -3.59% |
| 2027 | ₹43.26 | -13.61% |
| 2028 | ₹40.26 | -6.94% |
| 2029 | ₹43.07 | 6.97% |
| 2030 | ₹41.72 | -3.14% |
| 2031 | ₹45.91 | 10.04% |
| 2032 | ₹41.39 | -9.85% |
| 2033 | ₹40.57 | -1.99% |
| 2034 | ₹40.84 | 0.66% |
| 2035 | ₹122.3 | 199.46% |
| 2036 | ₹114.49 | -6.39% |
| 2037 | ₹117.13 | 2.3% |
| 2038 | ₹126.39 | 7.9% |
| 2039 | ₹124.48 | -1.52% |
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Sandu Pharmaceuticals Past Performance
- In 2002, Sandu Pharmaceuticals opening price was ₹3.85
- As of Fri 22 Nov 2024 the price stands at ₹56.79.
- This represents a Compound Annual Growth Rate (CAGR) of 12.41%.
- In 22 years, an investment of 10,000 would have become ₹1.47 Lakh.
As we wrap up, we hope you like our study on Sandu Pharmaceuticals share price predictions, please kindly note that these forecasts are based on technical analysis, past trends, and machine learning models. They are for educational purposes only, not investment advice.
Show Methodology We Use
Methodology Behind the Prediction
The share price predictions present on our site are derived from a robust model that incorporates multiple economic indicators, technical indicators, company performance metrics, and industry-specific factors.
We have historical share price data of all stocks for which we present targets, so we analyse historical trends from those past data and overlay them with projected market conditions to estimate future share prices of a stock.
- Sandu Pharmaceuticals Share Price History
- Sandu Pharmaceuticals Price Target Tomorrow
- Sandu Pharmaceuticals Dividend History
Disclaimer: Information is provided 'as is' and solely for informational and educational purposes, not for trading purposes or advice. We highly recommend to do your own research before making any investment.
